BBC Inside Science cover image

Net Zero

BBC Inside Science

00:00

The Clinical Benefits of Paying for a True Check Test

Dr Paul Korns is worried the test might find circulating cancer cells, but then it's highly unlikely to pinpoint where the tumor is. For every thousand people given this test, 44 in the trial done in India will test positive. We know that about a year later, of those 44 people, one will have had a diagnosed cancer. Do I think this is great science that has the potential to change screening? Absolutely. But for the moment, I think it's too early, and I wouldn't take it myself.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app